Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ET-26 versus etomidate for induction of general anesthesia in elective surgery
ChiCTR2400083014Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in None comparing ET-26 with Etomidate (2 arms). Primary endpoint: Success rate of anesthesia induction. Started Apr 2024; status: completed.
02
Drugs
methoxyethyl etomidateetomidate
Beyond the preview
Go deeper on ChiCTR2400083014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083014.